Safety-In-A-Box

Safety-In-A-Box (SIAB) is a cloud-native, AI-powered pharmacovigilance (PV) platform developed by RxLogix. It is designed to unify the full PV lifecycle into a single, scalable ecosystem, covering everything from case intake through regulatory submission. The platform targets pharmaceutical and biotech organizations seeking to reduce manual effort, accelerate compliance workflows, and manage safety operations across global regions without switching between multiple systems.

SIAB uses built-in natural language processing (NLP) and machine learning (ML) tools to handle intake, triage, and case coding. It supports E2B intake through ICSR submissions, provides real-time compliance dashboards, and is fully enabled for Japanese-language intake, triage, and reporting alongside other global languages.

Key Operational Capabilities

• End-to-end PV workflow management on a single platform, from E2B intake to ICSR regulatory submissions
• AI-driven case intake and processing, with reported 60–80% faster processing and 40–60% fewer false positives
• NLP and ML tools for automated intake, triage, and case coding
• Signal detection, management, evaluation, and reporting with reported 2–3× acceleration in cycle times
• Real-time dashboards providing continuous visibility into compliance, quality, and performance metrics
• Proactive alerts and monitoring for early detection of deviations, trends, and risks
• Multilingual support including native Japanese-language intake, triage, and reporting for local compliance
• Follow-the-sun operational enablement for global PV teams across multiple time zones and regulatory jurisdictions

Efficiency and Cost Metrics

• 40–65% improvement in operational efficiency through end-to-end workflow automation
• 60–80% reduction in manual case handling effort
• 30%+ reduction in Total Cost of Ownership (TCO) across PV operations
• 30–50% reduction in infrastructure and maintenance overhead through cloud-native architecture
• 20–40% productivity gains through intelligent workload distribution
• 50–70% faster implementation timelines compared to legacy PV platforms, with production-ready deployments achievable in weeks
• 30–50% fewer compliance gaps through proactive monitoring and alerts

Security and Compliance

• Continuous compliance with GxP, HIPAA, FDA, EMA, GDPR, and global regulatory standards
• ISO/IEC 27001 and SOC 2 Type II certified for data protection
• 100% audit-ready traceability with role-based access controls, full audit trails, and evidentiary logging
• EU data-privacy aligned; supports Japanese data residency requirements
• VPN-secured access and automated provisioning
• 99.9%+ platform availability with continuous monitoring and incident response

Use Cases

• Global case intake and processing: automated intake, triage, and coding for all case formats using AI-powered workflows
• Regulatory reporting and compliance: timely submissions adhering to EU, FDA, and local regulations
• Signal detection and risk management: identification of emerging safety signals using advanced analytics
• Clinical and post-marketing surveillance: integrated safety management across trials and commercial products
• Multi-language and regional readiness: handling Japanese and other local compliance requirements
• Enterprise scalability: supporting large case volumes and global teams via cloud-based architecture

Architecture and Integration

• AWS-based, multi-tenant cloud architecture with fully validated hosting for scalability and reliability
• API-first design with no Citrix dependency, enabling rapid scale-up or scale-down without re-platforming
• REST APIs for connectivity with CTMS, EDC, and partner systems
• Pre-built integrations with Argus, Aris Global, Veeva, Salesforce, and Medidata
• Hybrid and cloud deployment options supported
• Direct access to system consoles and databases for transparency and faster issue resolution

SIAB is available with optional managed services covering continuous compliance, operational support, and PV outsourcing. The platform offers 24/7 managed support with enterprise-grade SLAs and 99.95% reported availability. It has been audited by large pharma and biotech organizations and supports PV outsourcing options including safety operations in Japan.